WOBURN, Mass., Aug. 5, 2019 /PRNewswire/ -- Bio2 Technologies, Inc., the developer of Vitrium, a unique proprietary structural and resorbable orthobiomaterial, announced the first implantation of an index patient in its randomized, multi-center, non-inferiority IDE Vitrium Cervical Interbody clinical trial.  Bio2 received FDA approval to conduct the trial after

SAN DIEGO, Aug. 5, 2019 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it will release financial results for the three and six months ended June 30,

SAN CARLOS, Calif., Aug. 5, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced results of a prospective validation stud

REHOVOT, Israel and BRIDGEWATER, N.J., Aug. 5, 2019 /PRNewswire/ -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in dermatology, today announced that it has submitted a New Drug Application (

SEATTLE, Aug. 5, 2019 /PRNewswire/ -- A new RealSelf survey conducted online by The Harris Poll¹ reveals 59 percent of women in the U.S. do not know there is a difference be

SEATTLE, Aug. 5, 2019 /PRNewswire/ -- RealSelf, the leading online resource to learn about aesthetic procedures and connect with the doctors who provide them, today introduces RealSelf Verifi

AVONDALE, Pa., Aug. 5, 2019 /PRNewswire/ -- Qfix and Mevion Medical Systems are pleased to announce that a special version of the

RICHTON, Miss., Aug. 5, 2019 /PRNewswire/ -- A new and innovative Transitional Care program has been implemented in Richton, Mississippi thanks to a collaboration between Perry County General Hospital and Allevant Solutions, a joint venture between Mayo Clinic and Select Medical. "Transitional Care is for patients who have bee

MONROE TOWNSHIP, N.J., Aug. 5, 2019 /PRNewswire/ -- Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business, today announced the Food and Drug FDA approval for VARIBAR® THIN LIQUID (barium sulfate) for oral suspension which is indicated for modified barium swallow (MBS)

RIDGEFIELD, Conn., Aug. 5, 2019 /PRNewswire/ -- Boehringer Ingelheim today announced updated, interim analysis results from the GioTag study, showing that initiatin